Fundraising Fox

John Evans

Chief Executive Officer and Board Member at Beam Therapeutics

Cambridge, Massachusetts, United States

Find your path to John

1,114 people in our graph share verified history with John — schools, employers, funds. One of them is your warm intro.

René KuijtenunlockedJohn: together at McKinsey & Company (2001–2006)
×2John: together at Yale University
×2John: together at Agios Pharmaceuticals
×2John: together at Beam Therapeutics

About

He came to Beam in 2017 from Agios Pharmaceuticals, where he spent eight years as SVP of corporate development and portfolio leadership and served as IDH portfolio executive, and he also worked as a venture partner at ARCH Venture Partners. Earlier in his career he was a director of product development at Infinity Pharmaceuticals and held business analyst and senior associate roles at McKinsey & Company.

Chief Executive Officer and Board Member at Beam Therapeutics

Intro paths

In turn, John can intro founders to Beam Therapeutics's investors below.

Co-founders at Beam Therapeutics

DRDavid R. Liu
David R. LiuFounder and Inventor
JKJ. Keith Joung
J. Keith JoungFounder and Inventor
FZFeng Zhang
Feng ZhangFounder and Inventor
DRDavid R. Liu, Ph.D.
David R. Liu, Ph.D.Founder and Inventor
JKJ. Keith Joung, M.D., Ph.D.
J. Keith Joung, M.D., Ph.D.Founder and Inventor
FZFeng Zhang, Ph.D.
Feng Zhang, Ph.D.Founder and Inventor

Experience

  1. Beam TherapeuticsCEOcurrent2017 — presentCambridge, MA
  2. ARCH Venture PartnersVenture Partner2017 — 2021Cambridge, MA
  3. Agios PharmaceuticalsSVP, Corporate Development and Portfolio Leadership / IDH Portfolio Executive2009 — 2017
  4. Infinity PharmaceuticalsDirector, Product Development2006 — 2009
  5. McKinsey & CompanySenior Associate2005 — 2006
  6. MedImmuneSummer Associate, Corporate Development2004
  7. McKinsey & CompanyBusiness Analyst2001 — 2003

Skills & more

Strategy5Biotechnology17Life Sciences5Corporate Development2Business Development10Pharmaceutical Industry8Lifesciences3Product Development7Oncology4Drug Development4

From John's professional profile.

Frequently asked questions

Who is John Evans?
He came to Beam in 2017 from Agios Pharmaceuticals, where he spent eight years as SVP of corporate development and portfolio leadership and served as IDH portfolio executive, and he also worked as a venture partner at ARCH Venture Partners. Earlier in his career he was a director of product development at Infinity Pharmaceuticals and held business analyst and senior associate roles at McKinsey & Company.
Where does John Evans work?
John Evans is Chief Executive Officer and Board Member at Beam Therapeutics.
Where did John Evans go to school?
John Evans studied at The Wharton School (MBA, Healthcare Management); University of Pennsylvania (MA, Biotechnology); Yale University (BA, English).

Founder mafias

McKinsey & Company mafia736

Also came through, then founded or led a company.

+ 729 more

The Wharton School mafia570

Also came through, then founded or led a company.

+ 563 more

Yale University mafia373

Also came through, then founded or led a company.

+ 366 more

ARCH Venture Partners mafia16

Also came through, then founded or led a company.

+ 9 more

Agios Pharmaceuticals mafia4

Also came through, then founded or led a company.

Same school

Shared employers